Keros Therapeutics Inc (NASDAQ: KROS): Do Not Miss The Gain Train
Keros Therapeutics Inc (KROS) concluded trading on Thursday at a closing price of $12.24, with 3.95 million shares of worth about $48.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -79.49% during that period and on April 10, 2025 the price saw a […]
